Late anastomotic dehiscence during bevacizumab therapy for patients with colorectal cancer

MeSH terms

• Adenocarcinoma / drug therapy*
• Adenocarcinoma / surgery*
• Anastomotic Leak / chemically induced
• Antibodies, Monoclonal, Humanized / administration & dosage
• Antibodies, Monoclonal, Humanized / adverse effects*
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / adverse effects*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Bevacizumab
• Camptothecin / administration & dosage
• Camptothecin / adverse effects
• Camptothecin / analogs & derivatives
• Colorectal Neoplasms / drug therapy*
• Colorectal Neoplasms / surgery*
• Female
• Fluorouracil / administration & dosage
• Fluorouracil / adverse effects
• Humans
• Leucovorin / administration & dosage
• Leucovorin / adverse effects
• Male
• Middle Aged
• Neoplasm Grading
• Organoplatinum Compounds / administration & dosage
• Organoplatinum Compounds / adverse effects
• Surgical Wound Dehiscence / chemically induced*